Terms: = Breast cancer AND AFP, AFPD, FETA, HPAFP AND Prognosis
27 results:
1. Conversion of primary liver cancer after targeted therapy for liver cancer combined with afp-targeted CAR T-cell therapy: a case report.
Wang Y; Zhao Y; Li M; Hou H; Jian Z; Li W; Li P; Ma F; Liu M; Liu H; Xue H
Front Immunol; 2023; 14():1180001. PubMed ID: 37256142
[TBL] [Abstract] [Full Text] [Related]
2. Methylated SEPT9 assay-based liquid biopsy as a biomarker in molecular targeted agent-treated hepatocellular carcinoma.
Saeki I; Suehiro Y; Yamauchi Y; Hoshida T; Tanabe N; Oono T; Kawamoto D; Nishimura T; Matsumoto T; Ishikawa T; Shimokawa M; Tamori A; Kawada N; Tamai Y; Iwasa M; Nakagawa H; Nagano H; Takami T; Yamasaki T
Hepatol Int; 2023 Oct; 17(5):1289-1299. PubMed ID: 37186217
[TBL] [Abstract] [Full Text] [Related]
3. Multi-omics profiling of papillary thyroid microcarcinoma reveals different somatic mutations and a unique transcriptomic signature.
Li Q; Feng T; Zhu T; Zhang W; Qian Y; Zhang H; Zheng X; Li D; Yun X; Zhao J; Li Y; Yu H; Gao M; Qian B
J Transl Med; 2023 Mar; 21(1):206. PubMed ID: 36941725
[TBL] [Abstract] [Full Text] [Related]
4. Impact of Geriatric Nutritional Risk Index After Initial Hepatectomy for Hepatocellular Carcinoma: a Retrospective Cohort Study with the Hiroshima Surgical Study Group of Clinical Oncology (HiSCO).
Imaoka Y; Ohira M; Kobayashi T; Honmyo N; Hamaoka M; Onoe T; Abe T; Oishi K; Inoue M; Ohdan H;
J Gastrointest Surg; 2023 Jun; 27(6):1152-1158. PubMed ID: 36869207
[TBL] [Abstract] [Full Text] [Related]
5. Validation of quantitative prognostic prediction using ADV score for resection of hepatocellular carcinoma: A Korea-Japan collaborative study with 9200 patients.
Kang WH; Hwang S; Kaibori M; Kim JM; Kim KS; Kobayashi T; Kayashima H; Koh YS; Kubota K; Mori A; Takeda Y; Yun SS; Matsui K; Toriguchi K; Nagano H; Yoon MH; Soejima Y; Ariizumi S; Kim BS; Park Y; Yu HC; Kim BW; Lee JB; Park SJ; Jang JY; Yamaue H; Nakamura M; Yamamoto M; Endo I; ;
J Hepatobiliary Pancreat Sci; 2023 Aug; 30(8):993-1005. PubMed ID: 36808234
[TBL] [Abstract] [Full Text] [Related]
6. The Impact of a History of Different Other cancers on the Long-Term Outcomes of Patients with Intrahepatic Cholangiocarcinoma: A Population-Based Analysis.
Chai J; Kong J; Zhu K
Biomed Res Int; 2022; 2022():3970884. PubMed ID: 35257009
[TBL] [Abstract] [Full Text] [Related]
7. Lectin Affinity Chromatography for the Discovery of Novel cancer Glycobiomarkers: A Case Study with PSA Glycoforms and Prostate cancer.
Llop E; Peracaula R
Methods Mol Biol; 2022; 2370():301-313. PubMed ID: 34611876
[TBL] [Abstract] [Full Text] [Related]
8. Ultrasensitive, high-throughput and multiple cancer biomarkers simultaneous detection in serum based on graphene oxide quantum dots integrated microfluidic biosensing platform.
Wang C; Zhang Y; Tang W; Wang C; Han Y; Qiang L; Gao J; Liu H; Han L
Anal Chim Acta; 2021 Sep; 1178():338791. PubMed ID: 34482866
[TBL] [Abstract] [Full Text] [Related]
9. Expression of Pregnancy Up-regulated Non-ubiquitous Calmodulin Kinase (PNCK) in Hepatocellular Carcinoma.
Cho YA; Choi S; Park S; Park CK; Ha SY
Cancer Genomics Proteomics; 2020; 17(6):747-755. PubMed ID: 33099476
[TBL] [Abstract] [Full Text] [Related]
10. Is gynecomastia related to the disease characteristics and prognosis in testicular germ cell tumor patients?
Polat AV; Öztürk M; Çamlıdağ İ; Akyüz B
Diagn Interv Radiol; 2019 May; 25(3):189-194. PubMed ID: 31063146
[TBL] [Abstract] [Full Text] [Related]
11. FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma.
Zhong CQ; Zhang XP; Ma N; Zhang EB; Li JJ; Jiang YB; Gao YZ; Yuan YM; Lan SQ; Xie D; Cheng SQ
Cancer Med; 2018 Jun; 7(6):2629-2640. PubMed ID: 29733540
[TBL] [Abstract] [Full Text] [Related]
12. Evaluation of Osteopontin as a Biomarker in Hepatocellular Carcinomas in Egyptian Patients with Chronic HCV Cirrhosis.
Abdel-Hafiz SM; Hamdy HE; Khorshed FM; Aboushousha TS; Safwat G; Saber MA; Seleem M; Soliman AH
Asian Pac J Cancer Prev; 2018 Apr; 19(4):1021-1027. PubMed ID: 29693976
[TBL] [Abstract] [Full Text] [Related]
13. EVI5 is a novel independent prognostic predictor in hepatocellular carcinoma after radical hepatectomy.
Tang J; Ou J; Xu C; Yi C; Xue F; Xu L; Lai F; Tang J; Li S; Kang T; Ding W; Wang B
Oncol Rep; 2017 Oct; 38(4):2251-2258. PubMed ID: 28765910
[TBL] [Abstract] [Full Text] [Related]
14. Sensitive and Quantitative Detection of C-Reaction Protein Based on Immunofluorescent Nanospheres Coupled with Lateral Flow Test Strip.
Hu J; Zhang ZL; Wen CY; Tang M; Wu LL; Liu C; Zhu L; Pang DW
Anal Chem; 2016 Jun; 88(12):6577-84. PubMed ID: 27253137
[TBL] [Abstract] [Full Text] [Related]
15. CT measurement of breast glandular tissue and its association with testicular cancer.
Klang E; Rozendorn N; Raskin S; Portnoy O; Sklair M; Marom EM; Konen E; Amitai MM
Eur Radiol; 2017 Feb; 27(2):536-542. PubMed ID: 27229339
[TBL] [Abstract] [Full Text] [Related]
16. High expression of hexokinase domain containing 1 is associated with poor prognosis and aggressive phenotype in hepatocarcinoma.
Zhang Z; Huang S; Wang H; Wu J; Chen D; Peng B; Zhou Q
Biochem Biophys Res Commun; 2016 Jun; 474(4):673-679. PubMed ID: 27155152
[TBL] [Abstract] [Full Text] [Related]
17. Downregulated Expression of PTPN9 Contributes to Human Hepatocellular Carcinoma Growth and Progression.
Hu B; Yan X; Liu F; Zhu C; Zhou H; Chen Y; Liu J; Gu X; Ni R; Zhang T
Pathol Oncol Res; 2016 Jul; 22(3):555-65. PubMed ID: 26715439
[TBL] [Abstract] [Full Text] [Related]
18. Effects of interval between age at first pregnancy and age at diagnosis on breast cancer survival according to menopausal status: a register-based study in Korea.
Lee J; Oh M;
BMC Womens Health; 2014 Sep; 14():113. PubMed ID: 25231360
[TBL] [Abstract] [Full Text] [Related]
19. α-fetoprotein produced by endometrioid adenocarcinoma of uterus.
Akhavan A; Karimi Zarchi M; Akhavan Tafti M; Navabii H
BMJ Case Rep; 2012 Jun; 2012():. PubMed ID: 22736779
[TBL] [Abstract] [Full Text] [Related]
20. Clinical significance and prognostic value of serum sHER-2/neu levels in patients with solid tumors.
Papila C; Uzun H; Balci H; Zerdali H; Sezgin C; Can G; Yanardag H
Med Oncol; 2009; 26(2):151-6. PubMed ID: 18855148
[TBL] [Abstract] [Full Text] [Related]
[Next]
